Analysis of the direct economic impact of smoking-related hospitalizations in Italy.

Italy burden of disease cost of illness smoking tobacco

Journal

Tobacco induced diseases
ISSN: 1617-9625
Titre abrégé: Tob Induc Dis
Pays: Greece
ID NLM: 101201591

Informations de publication

Date de publication:
2024
Historique:
received: 11 03 2024
revised: 24 04 2024
accepted: 29 04 2024
medline: 4 6 2024
pubmed: 4 6 2024
entrez: 4 6 2024
Statut: epublish

Résumé

Tobacco-related diseases have a substantial economic impact in terms of medical expenses, loss of productivity, and premature death. Tobacco use is estimated to be responsible for more than 90000 deaths each year in Italy. We aimed to evaluate the annual direct economic impact on the National Health System of hospitalizations attributable to tobacco smoking in Italy. We analyzed data from all the hospitalizations of patients aged ≥30 years that occurred in Italy for 12 selected tobacco-related diseases, during 2018. These diseases included oropharyngeal cancer, esophageal cancer, gastric cancer, lung cancer, pancreatic cancer, bladder cancer, laryngeal cancer, ischemic heart disease, stroke, diseases of arteries, arterioles, and capillaries, pneumonia and influenza, and chronic obstructive pulmonary disease. We obtained information on 984322 hospital discharge records, including each hospitalization's direct costs. Using relative risk estimates from the scientific literature, we computed the population attributable fraction for various tobacco-related diseases to estimate the economic impact attributable to tobacco smoking. One-third of all hospitalizations occurred in 2018 in Italy among people aged ≥30 years for 12 tobacco-related diseases were found to be attributable to smoking, accounting for a total cost of €1.64 billion. Among the diseases considered, those with the highest expenditures attributable to tobacco smoking were ischemic heart disease, cerebrovascular disease, and lung cancer, accounting for €556 million, €290 million, and €229 million, respectively. Tobacco has a substantial economic impact in Italy, accounting for around 6% of the total cost of hospitalizations in 2018. This figure is expected to be largely underestimated due to several conservative assumptions adopted in the statistical analyses. It is imperative to prioritize comprehensive tobacco control measures to counteract the huge healthcare costs due to tobacco smoking.

Identifiants

pubmed: 38832050
doi: 10.18332/tid/188111
pii: TID-22-96
pmc: PMC11145629
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

© 2024 Possenti I. et al.

Déclaration de conflit d'intérêts

The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.

Auteurs

Irene Possenti (I)

Department of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Marco Scala (M)

Department of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Magda Rognoni (M)

Epidemiology Unit, Local Health Authority (ATS - Agenzia per la Tutela della Salute) Brianza, Monza, Italy.

Alessandra Lugo (A)

Department of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Maria S Cattaruzza (MS)

Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.

Sabrina Molinaro (S)

Institute of Clinical Physiology, Italian National Research Council, Pisa, Italy.

Anna Odone (A)

Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.

Luc J M Smits (LJM)

Department of Epidemiology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

Vincenzo Zagà (V)

Società Italiana di Tabaccologia, Rome, Italy.

Silvano Gallus (S)

Department of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Luca Cavalieri d'Oro (LC)

Epidemiology Unit, Local Health Authority (ATS - Agenzia per la Tutela della Salute) Brianza, Monza, Italy.

Classifications MeSH